Brief: Grand Pharmaceutical Sees HY Consolidated Net Profit Attributable Increased By Not Less Than 50%
14/08/2024 11:21
Aug 14 (Reuters) - Grand Pharmaceutical Group Ltd
0512.HK :
* SEES HY CONSOLIDATED NET PROFIT ATTRIBUTABLE INCREASED BY
NOT
LESS THAN 50%
* EXPECTED RESULT DUE TO FAIR VALUE CHANGE IN GROUP'S
INVESTMENT
IN TELIX PHARMACEUTICALS, OTHERS
Further company coverage: 0512.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Grand Pharmaceutical
See all newsBrief: Grand Pharmaceutical Group Declares No Interim Dividend Has Been Paid
Grand Pharmaceutical H1 revenue rises on nuclear medicine demand
Grand Pharma rises most in over a year as drug gets US FDA fast track designation
GPN01530-2 Granted Fast Track Designation By FDA
Brief: Grand Pharmaceutical Group Enters Huadong Medicine Supply Agreement